Protocol No
CARIBOU-CB10A-ANTLER-NHL
Staff Member
Mehdi Hamadani
Phase
I
Summary
To find out what effects the CB-010 therapy may have on your
cancer.
Objective
CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell NHL
Study Sites
Froedtert Hospital
Status
OPEN TO ACCRUAL
Categories
ClinicalTrials.gov